Illumina, Inc. (ILMN) Analysts See $1.40 EPS; Dodge & Cox Has Cut Its Ball (BLL) Position

Illumina, Inc. (NASDAQ:ILMN) Logo

Dodge & Cox decreased Ball Corp (BLL) stake by 2.45% reported in 2019Q1 SEC filing. Dodge & Cox sold 60,650 shares as Ball Corp (BLL)’s stock rose 13.24%. The Dodge & Cox holds 2.42M shares with $139.76 million value, down from 2.48M last quarter. Ball Corp now has $23.43 billion valuation. The stock decreased 1.62% or $1.15 during the last trading session, reaching $70. About 1.56 million shares traded. Ball Corporation (NYSE:BLL) has risen 62.96% since July 14, 2018 and is uptrending. It has outperformed by 58.53% the S&P500. Some Historical BLL News: 13/04/2018 – New York Post: Lonzo Ball is set to crush all that hype next season; 09/05/2018 – Global Cryogenic Valve (Globe, Gate, Ball) Market 2018-2023 – Focus on Tanks & Cold Boxes, Transfer Lines, Manifolds & Gas Trains Applications – ResearchAndMarkets.com; 26/04/2018 – Ball Aerospace Conducted Successful Evaluation of Testbed for DARPA’s Hallmark Program; 04/04/2018 – The HKTB Boosts Hong Kong Sevens Promotions; Giant Rugby Ball in Victoria Harbour Bringing a Festive Ambiance to Town; 22/05/2018 – InventHelp Inventor Develops Entertaining Bowling Ball (KOC-703); 16/05/2018 – New York Today: New York Today: One Ball and a Wall; 25/04/2018 – New York Post: Angry LaVar Ball abruptly pulls sons out of Lithuania; 04/05/2018 – Saga of the Toxic Ball Fields; 19/04/2018 – Legendary Sowden House Opens Doors to The Public Exclusively For “Pawtastic Ball” Benefitting The Little Red Dog, Inc. Rescue; 29/03/2018 – AUSTRALIA COACH LEHMANN SAYS FAMILY RECEIVED BACKLASH AFTER BALL-TAMPERING SCANDAL, RESIGNED VOLUNTARILY

Analysts expect Illumina, Inc. (NASDAQ:ILMN) to report $1.40 EPS on July, 29.They anticipate $0.03 EPS change or 2.10% from last quarter’s $1.43 EPS. ILMN’s profit would be $205.80M giving it 54.47 P/E if the $1.40 EPS is correct. After having $1.60 EPS previously, Illumina, Inc.’s analysts see -12.50% EPS growth. The stock decreased 16.12% or $58.61 during the last trading session, reaching $305.05. About 8.30M shares traded or 678.79% up from the average. Illumina, Inc. (NASDAQ:ILMN) has risen 13.78% since July 14, 2018 and is uptrending. It has outperformed by 9.35% the S&P500. Some Historical ILMN News: 13/04/2018 – BRISTOL-MYERS SQUIBB AND ILLUMINA ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE COMPANION DIAGNOSTICS FOR BRISTOL-MYERS SQUIBB’S ONCOLOGY IMMUNOTHERAPIES; 15/05/2018 – Illumina Acquired Edico Genome; 24/04/2018 – ILLUMINA INC ILMN.O SEES FY 2018 NON-GAAP SHR $4.75 TO $4.85; 24/04/2018 – ILLUMINA INC ILMN.O FY2018 SHR VIEW $4.59, REV VIEW $3.14 BLN — THOMSON REUTERS l/B/E/S; 24/04/2018 – ILLUMINA INC – FOR FISCAL 2018, COMPANY NOW PROJECTS GAAP EARNINGS PER DILUTED SHARE ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS OF $4.45 TO $4.55; 15/05/2018 – Illumina Presenting at Bank of America Conference Tomorrow; 02/05/2018 – Illumina to Webcast Upcoming Investor Conference Presentation; 24/05/2018 – Kaskela Law LLC Announces Investigation of Illumina, Inc. on Behalf of Stockholders; 29/03/2018 – SiriusDecisions Recognizes Cisco, Huron Consulting Group, Illumina, Imprivata and Vocera as Winners of the 2018 Return on; 10/04/2018 – Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Since January 23, 2019, it had 0 insider purchases, and 6 sales for $3.41 million activity. Another trade for 124 shares valued at $34,734 was made by Dadswell Charles on Friday, February 1. FLATLEY JAY T sold $969,078 worth of stock or 3,300 shares. deSouza Francis A also sold $848,854 worth of Illumina, Inc. (NASDAQ:ILMN) shares. 1,000 shares valued at $280,110 were sold by EPSTEIN ROBERT S on Friday, February 1.

More notable recent Illumina, Inc. (NASDAQ:ILMN) news were published by: Finance.Yahoo.com which released: “Will Illumina, Inc.’s (NASDAQ:ILMN) Earnings Grow Over The Next Year? – Yahoo Finance” on July 12, 2019, also Finance.Yahoo.com with their article: “Is Now An Opportune Moment To Examine Illumina, Inc. (NASDAQ:ILMN)? – Yahoo Finance” published on July 01, 2019, Seekingalpha.com published: “Illumina down 15% after hours on softer guidance – Seeking Alpha” on July 11, 2019. More interesting news about Illumina, Inc. (NASDAQ:ILMN) were released by: Nasdaq.com and their article: “Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know – Nasdaq” published on July 09, 2019 as well as Nasdaq.com‘s news article titled: “Illumina (ILMN) Hits 52-Week High, Can the Run Continue? – Nasdaq” with publication date: July 08, 2019.

Investors sentiment increased to 1.33 in Q1 2019. Its up 0.15, from 1.18 in 2018Q4. It improved, as 37 investors sold Illumina, Inc. shares while 204 reduced holdings. 85 funds opened positions while 235 raised stakes. 170.65 million shares or 23.60% more from 138.07 million shares in 2018Q4 were reported. Eqis Cap Mngmt invested in 8,682 shares. Louisiana State Employees Retirement System holds 7,800 shares or 0.12% of its portfolio. Jackson Square Prtnrs Ltd Liability Company, California-based fund reported 1.13 million shares. Aspiriant Limited Co stated it has 1,582 shares. Swiss Comml Bank invested 0.17% of its portfolio in Illumina, Inc. (NASDAQ:ILMN). First Republic Investment Mngmt holds 0.03% or 15,624 shares in its portfolio. Metropolitan Life Insur New York holds 0.01% in Illumina, Inc. (NASDAQ:ILMN) or 35,564 shares. First Hawaiian Bancorp holds 0% or 280 shares in its portfolio. Guggenheim Capital Ltd holds 0.24% or 94,456 shares. Hall Laurie J Trustee holds 0.21% or 1,255 shares in its portfolio. Rampart Mngmt Ltd Liability Corp holds 0.19% or 5,364 shares in its portfolio. State Of Tennessee Treasury Department accumulated 0.18% or 120,284 shares. Acadian Asset Management Ltd Llc invested in 10,163 shares. Castleark has invested 1.23% in Illumina, Inc. (NASDAQ:ILMN). 100 were reported by Schroder Gp.

Illumina, Inc. provides sequencing and array solutions for genetic analysis. The company has market cap of $44.84 billion. The companyÂ’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It has a 53.33 P/E ratio. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array.

Among 4 analysts covering Ball (NYSE:BLL), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Ball had 11 analyst reports since January 17, 2019 according to SRatingsIntel. The stock has “Outperform” rating by Wells Fargo on Thursday, February 21. On Wednesday, April 17 the stock rating was maintained by Morgan Stanley with “Overweight”. As per Friday, April 5, the company rating was maintained by Citigroup. The firm has “Outperform” rating given on Friday, May 17 by Wells Fargo. The firm has “Outperform” rating given on Wednesday, February 13 by BMO Capital Markets. The rating was maintained by Morgan Stanley with “Overweight” on Wednesday, June 5. Citigroup maintained Ball Corporation (NYSE:BLL) on Thursday, July 11 with “Buy” rating. The firm has “Neutral” rating by UBS given on Friday, February 15.

Dodge & Cox increased Baidu Inc (NASDAQ:BIDU) stake by 10,100 shares to 4.95 million valued at $816.06 million in 2019Q1. It also upped Cvs Health Corp (NYSE:CVS) stake by 3.80M shares and now owns 19.85 million shares. Booking Holdings Inc was raised too.

Investors sentiment decreased to 0.86 in Q1 2019. Its down 0.49, from 1.35 in 2018Q4. It turned negative, as 36 investors sold BLL shares while 173 reduced holdings. 74 funds opened positions while 105 raised stakes. 262.22 million shares or 4.96% less from 275.89 million shares in 2018Q4 were reported. Marsico Cap Mgmt Limited Liability has 97,319 shares. Of Vermont reported 114 shares. Livforsakringsbolaget Skandia Omsesidigt owns 2,914 shares. Allstate invested 0.12% in Ball Corporation (NYSE:BLL). Sumitomo Life Ins accumulated 28,695 shares. 32,392 were reported by Ameritas Prtn. Nuwave Invest Mgmt Limited Liability reported 21,149 shares. Moreover, Obermeyer Wood Invest Counsel Lllp has 4.58% invested in Ball Corporation (NYSE:BLL) for 842,119 shares. Barclays Public Limited Com has 0.04% invested in Ball Corporation (NYSE:BLL). The Alabama-based Regions Fincl has invested 0% in Ball Corporation (NYSE:BLL). Azimuth Capital Mngmt Ltd Limited Liability Company holds 0.41% or 105,492 shares. Hightower Ltd Liability Corporation reported 34,676 shares. First Foundation has 1.35% invested in Ball Corporation (NYSE:BLL). Hartford Inv holds 36,403 shares. Sumitomo Mitsui Asset Management Ltd holds 0.02% or 22,244 shares in its portfolio.

More notable recent Ball Corporation (NYSE:BLL) news were published by: Finance.Yahoo.com which released: “Have Insiders Been Selling Ball Corporation (NYSE:BLL) Shares? – Yahoo Finance” on June 18, 2019, also Finance.Yahoo.com with their article: “Here’s What Hedge Funds Think About Ball Corporation (BLL) – Yahoo Finance” published on June 20, 2019, Fool.com published: “Why Ball Corporation Stock Climbed 14% in June – Motley Fool” on July 06, 2019. More interesting news about Ball Corporation (NYSE:BLL) were released by: Prnewswire.com and their article: “Ball to Announce Second Quarter Earnings on August 1, 2019 – PRNewswire” published on July 01, 2019 as well as Finance.Yahoo.com‘s news article titled: “A Spotlight On Ball Corporation’s (NYSE:BLL) Fundamentals – Yahoo Finance” with publication date: May 31, 2019.

Analysts await Ball Corporation (NYSE:BLL) to report earnings on August, 1. They expect $0.65 EPS, up 12.07% or $0.07 from last year’s $0.58 per share. BLL’s profit will be $217.58M for 26.92 P/E if the $0.65 EPS becomes a reality. After $0.49 actual EPS reported by Ball Corporation for the previous quarter, Wall Street now forecasts 32.65% EPS growth.

Illumina, Inc. (NASDAQ:ILMN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.